Christopher Dinsmore - 12 Dec 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Scientific Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
12 Dec 2023
Net transactions value
-$13,092
Form type
4
Filing time
13 Dec 2023, 16:10:12 UTC
Previous filing
07 Jul 2023
Next filing
05 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Sale $13,092 -10,032 -3.6% $1.30 268,335 12 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
F2 The weighted average sale price for the transaction reported was $1.305, and the range of prices were between $1.215 to $1.41. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.